Opendata, web and dolomites
AMGEN (Belgium): list of projects
The following table shows the list of Horizon 2020 projects developed by "AMGEN". Projects are ordered by starting date.
Click on table headers to rearrange data.
| # | acronym | programme | role | EC contrib. | start | views |
|---|---|---|---|---|---|---|
| 1 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 0.00 | 2015-07-01 | 663 |
| 2 | HARMONY | H2020-EU.3.1.7. | participant | 0.00 | 2017-01-01 | 899 |
| 3 | DO-IT | H2020-EU.3.1.7. | participant | 0.00 | 2017-02-01 | 983 |
| totale | 0.00 | |||||
Network analysis
This organization collaborated with partners in 17 countries.
ADAPT-SMART
Within the project ADAPT-SMART this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
| participant | UK | AbbVie | AbbVie Ltd (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
| participant | FR | Lysogene | LYSOGENE (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
| participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
| participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
| participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
| participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
| participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
| participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
| participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
| coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | DE | Bayer | Bayer Pharma AG (PRC) |
| participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
| participant | UK | PFIZER | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
| participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
HARMONY
Within the project HARMONY this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | FR | LYSA | THE LYMPHOMA STUDY ASSOCIATION (REC) |
| participant | NL | VUmc | STICHTING VUMC (REC) |
| participant | FR | GRAALL | GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (REC) |
| participant | DE | GPOH | GPOH GEMEINNUTZIGE GMBH (REC) |
| participant | IT | FISMonlus | FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS (REC) |
| participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
| participant | DE | ERIC | EUROPEAN RESEARCH INITIATIVE ON CLL EV (REC) |
| participant | NL | EHA | EUROPEAN HEMATOLOGY ASSOCIATION (OTH) |
| participant | BE | EAPM | EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL (REC) |
| participant | DE | ELN Foundation | STIFTUNG ELN FOUNDATION (OTH) |
| participant | IT | Menarini | MENARINI RICERCHE SPA (PRC) |
| participant | US | ABBVIE | ABBVIE INC (PRC) |
| participant | ES | IJC | FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS (REC) |
| coordinator | ES | IECSCYL | FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON (REC) |
| participant | FI | MS | MEDISAPIENS OY (PRC) |
| participant | FR | GFM | GROUPE FRANCOPHONE DES MYELODYSPLASIES (REC) |
| participant | UK | Takeda EU | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
| participant | DE | LeukaNET | LEUKANET EV (OTH) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
| participant | DE | MLL | MLL MUNCHNER LEUKAMIELABOR GMBH (PRC) |
| participant | NL | EBMT | EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION (OTH) |
| participant | ES | VHIO | FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (REC) |
| participant | ES | HULAFE | FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (REC) |
| participant | ES | GMV | GMV SOLUCIONES GLOBALES INTERNET SAU (PRC) |
| participant | DE | Bayer | Bayer Pharma AG (PRC) |
| participant | UK | BHT | BARTS AND THE LONDON NHS TRUST (REC) |
| participant | DE | BfArM | BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE (PUB) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | IT | OPBG | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
| participant | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
| participant | ES | AEMPS | AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS (PUB) |
| participant | ES | UNAV | UNIVERSIDAD DE NAVARRA (HES) |
| participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
| participant | BE | VIB | VIB (REC) |
| participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
| participant | IT | URTV | UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA (HES) |
| participant | DE | UDUS | HEINRICH-HEINE-UNIVERSITAET DUESSELDORF (HES) |
| participant | IT | UNITO | UNIVERSITA DEGLI STUDI DI TORINO (HES) |
| participant | CZ | MU | Masarykova univerzita (HES) |
| participant | DE | UULM | UNIVERSITAET ULM (HES) |
| participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
| participant | UK | UoY | UNIVERSITY OF YORK (HES) |
| participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
| participant | DE | IAP | JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN (HES) |
| participant | UK | GRL | GENOME RESEARCH LIMITED (REC) |
| participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
| participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
| participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
| participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
| participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
| participant | FI | UHEL | HELSINGIN YLIOPISTO (HES) |
DO-IT
Within the project DO-IT this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
| participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
| participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
| participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
| participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
| participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
| participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
| participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
| participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
| participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
| participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
| participant | UK | Pfizer | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
| participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
| participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
| coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo | NOVO NORDISK A/S (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
| participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
| participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |